Completed PHASE3 INTERVENTIONAL 2-arm NCT03171142

Effect of Heliox on RSV Bronchiolitis

Effect of Heliox on Infants With Respiratory Syncytial Virus Acute Bronchiolitis-A Revisit Study

Sponsor: Wael Seliem

Conditions Acute Bronchiolitis RSV Infection

Interventions Air Heliox

Updated 5 times since 2017 Last updated: May 26, 2017 Started: May 1, 2015 Primary completion: Aug 1, 2016 Completion: May 1, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Acute Bronchiolitis and RSV Infection, this trial is completed. The trial is conducted by Wael Seliem and has accumulated 5 data snapshots since 2015. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jul 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

May 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Wael Seliem

Data source: Mansoura University Children Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.